Yayın:
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHacı Arak
dc.contributor.authorSuna Erkılıç
dc.contributor.authorŞendağ Yaslıkaya
dc.contributor.authorEda Eylemer Mocan
dc.contributor.authorGökmen Aktaş
dc.contributor.authorMelek Özdemir
dc.contributor.authorHüseyin Salih Semiz
dc.contributor.authorSaadettin Kılıçkap
dc.contributor.authorFaruk Recep Özalp
dc.contributor.authorÖzlem Nuray Sever
dc.contributor.authorGoncagül Akdağ
dc.contributor.authorAhmet Burak Ağaoğlu
dc.contributor.authorMelike Özçelik
dc.contributor.authorMurat Sarı
dc.contributor.authorMurat Arcagök
dc.contributor.authorHicran Anık
dc.contributor.authorŞaziye Burçak Yayla
dc.contributor.authorNadiye Sever
dc.contributor.authorFatma Pınar Açar
dc.contributor.authorİsmail Bayrakçı
dc.contributor.authorSerdar Turhal
dc.contributor.authorMurat Ayhan
dc.contributor.authorTülay Kuş
dc.contributor.authorTurkish Oncology Group Study
dc.contributor.orcid0000-0002-2023-423X
dc.contributor.orcid0000-0001-6722-8518
dc.contributor.orcid0000-0001-5264-8405
dc.contributor.orcid0000-0003-0429-8142
dc.contributor.orcid0000-0003-4199-6943
dc.contributor.orcid0000-0003-1894-9743
dc.contributor.orcid0000-0002-7083-8517
dc.contributor.orcid0000-0003-1637-7390
dc.contributor.orcid0000-0002-2863-3243
dc.contributor.orcid0000-0003-3462-9360
dc.contributor.orcid0000-0002-6221-0623
dc.contributor.orcid0000-0001-5528-7852
dc.contributor.orcid0000-0003-0406-715X
dc.contributor.orcid0000-0003-0596-1559
dc.contributor.orcid0000-0001-7726-7975
dc.contributor.orcid0009-0001-7992-4008
dc.contributor.orcid0009-0000-2749-8732
dc.contributor.orcid0000-0002-5785-8273
dc.contributor.orcid0000-0002-0631-4006
dc.contributor.orcid0000-0001-5781-4820
dc.date.accessioned2026-05-20T09:40:21Z
dc.date.issued2024-02-09
dc.identifier.doi10.1097/cji.0000000000000508
dc.identifier.endpage189
dc.identifier.issn1524-9557
dc.identifier.issue5
dc.identifier.openalexW4391684044
dc.identifier.startpage182
dc.identifier.urihttps://hdl.handle.net/11421/38556
dc.identifier.urihttps://doi.org/10.1097/cji.0000000000000508
dc.identifier.volume47
dc.language.isoen
dc.relation.ispartofJournal of Immunotherapy
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectAdjuvant therapy
dc.subjectAdjuvant
dc.subjectInternal medicine
dc.subjectMelanoma
dc.subjectGastroenterology
dc.subjectStage (stratigraphy)
dc.subjectOncology
dc.subjectSurgery
dc.subjectCancer
dc.subjectCancer research
dc.subject.sdg3
dc.titleThe Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications